Targeting the biochemical pathways that are dysregulated in cancer can be a therapeutic strategy. By applying Mass Action Law, researchers can predict how changes in the concentration of a drug or a protein inhibitor will affect the reaction rates within these pathways. This helps in designing effective treatment regimens and dosage plans.
